Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Long-Term Investments (2019 - 2022)

Silo Pharma (SILO) has disclosed Long-Term Investments for 4 consecutive years, with $77939.0 as the latest value for Q3 2022.

  • Quarterly Long-Term Investments fell 90.5% to $77939.0 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $77939.0 through Sep 2022, down 90.5% year-over-year, with the annual reading at $419995.0 for FY2021, 209897.5% up from the prior year.
  • Long-Term Investments hit $77939.0 in Q3 2022 for Silo Pharma, down from $419995.0 in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $820126.0 in Q3 2021 to a low of $200.0 in Q4 2020.
  • Historically, Long-Term Investments has averaged $196981.7 across 4 years, with a median of $12766.0 in 2019.
  • Biggest five-year swings in Long-Term Investments: crashed 97.87% in 2020 and later soared 209897.5% in 2021.
  • Year by year, Long-Term Investments stood at $9394.0 in 2019, then plummeted by 97.87% to $200.0 in 2020, then skyrocketed by 209897.5% to $419995.0 in 2021, then tumbled by 81.44% to $77939.0 in 2022.
  • Business Quant data shows Long-Term Investments for SILO at $77939.0 in Q3 2022, $419995.0 in Q4 2021, and $820126.0 in Q3 2021.